SecBot SecBot
SECBOTREPLAY Home › Report › EWTX

EWTX · CEO Kevin Koch and General Counsel John Moore sold a combined ~$468K in…

Edgewise Therapeutics, Inc. · CLUSTER filed Aug 14, 2026 at 16:54 ET

At the news

NEUTRALIMPACT 3/10

CLUSTER filed Aug 14, 2026 at 16:54 ET

CEO Kevin Koch and General Counsel John Moore sold a combined ~$468K in open-market sales on August 12, 2026, following the Q2 earnings miss and the close of the sevasemten sale to Servier. The sales are small relative to the $4.8B market cap (~0.01%) and are paired with large non-cash equity grants and derivative exercises, suggesting tax-related selling rather than a bearish signal. The cluster is neutral, the dollar value is trivial and the sales are likely liquidity-driven post-vesting.

  • CEO Kevin Koch sold 18,000 shares for ~$785K total (two trades on Aug 12 at ~$43.64-$44.33)
  • General Counsel John Moore sold 5,016 shares for ~$220K total (four trades on Aug 12 at ~$43.80-$44.50)
  • Both executives received large non-cash equity grants (Koch: 300,000 shares; Moore: 97,500 shares) on the same day
  • Total open-market sales of ~$1.0M represent ~0.02% of $4.8B market cap, well below materiality threshold

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access